儿童高级别胶质瘤疗效评估:RAPNO工作组推荐
国际儿童与成人神经肿瘤学、影像学、放疗及外科专家组成的RAPNO工作组,针对儿童高级别胶质瘤疗效评估的独特挑战,通过文献回顾与共识流程制定推荐。推荐包括脑与脊柱MRI、临床状态及皮质类固醇或抗血管生成药物使用评估,并定义影像标准;与成人推荐相比,儿童纳入弥散加权成像并更依赖T2-FLAIR。共识推荐与疗效定义已建立,尚需前瞻性临床试验验证。
要点
- 儿童高级别胶质瘤疗效评估推荐脑和脊柱MRI、临床状态及皮质类固醇或抗血管生成药物使用。
- 儿童影像标准纳入弥散加权成像,并更依赖T2加权FLAIR序列。
- 共识推荐与疗效定义尚需前瞻性临床试验验证。
核心结论
- RAPNO工作组已建立儿童高级别胶质瘤的共识疗效评估推荐与疗效定义。
- 这些推荐与成人高级别胶质瘤推荐不同,纳入弥散加权成像并更依赖T2加权FLAIR。
- 类似其他RAPNO推荐,儿童高级别胶质瘤推荐尚需前瞻性临床试验验证。
研究设计与样本
- RAPNO工作组由国际儿童与成人神经肿瘤学家、临床医生、放射科医生、放射肿瘤科医生和神经外科医生组成。
- 设立分委员会制定儿童高级别胶质瘤疗效评估标准。
- 通过回顾当前实践与文献识别评估挑战,在科学证据稀缺领域通过迭代流程达成共识。
主要发现
- RAPNO推荐包括使用脑和脊柱MRI、评估临床状态以及评估皮质类固醇或抗血管生成药物使用。
- 脑和脊柱的影像学标准已定义。
- 与成人高级别胶质瘤管理推荐相比,儿童推荐纳入弥散加权成像并更依赖T2加权液体衰减反转恢复序列。
关键数值与推荐
- RAPNO疗效评估推荐包括脑和脊柱MRI、临床状态评估以及皮质类固醇或抗血管生成药物使用评估。
- 儿童脑和脊柱影像标准已定义,纳入弥散加权成像并更依赖T2加权FLAIR。
- 共识推荐与疗效定义已建立,尚需前瞻性临床试验验证。
临床怎么用
- 临床评估儿童高级别胶质瘤疗效时,应采用RAPNO推荐的脑和脊柱MRI及临床状态评估。
- 需同时评估皮质类固醇或抗血管生成药物的使用情况。
- 影像评估应纳入弥散加权成像并更依赖T2加权FLAIR序列。
局限性
- 在科学调查稀缺的领域,推荐基于共识而非充分科学证据。
- 共识推荐与疗效定义尚需前瞻性临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Response criteria for paediatric high-grade glioma vary historically and across different cooperative groups. The Response Assessment in Neuro-Oncology working group developed response criteria for adult high-grade glioma, but these were not created to meet the unique challenges in children with the disease. The Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group, consisting of an international panel of paediatric and adult neuro-oncologists, clinicians, radiologists, radiation oncologists, and neurosurgeons, was established to address issues and unique challenges in assessing response in children with CNS tumours. We established a subcommittee to develop response assessment criteria for paediatric high-grade glioma. Current practice and literature were reviewed to identify major challenges in assessing the response of paediatric high-grade gliomas to various treatments. For areas in which scientific investigation was scarce, consensus was reached through an iterative process. RAPNO response assessment recommendations include the use of MRI of the brain and the spine, assessment of clinical status, and the use of corticosteroids or antiangiogenics. Imaging standards for brain and spine are defined. Compared with the recommendations for the management of adult high-grade glioma, for paediatrics there is inclusion of diffusion-weighted imaging and a higher reliance on T2-weighted fluid-attenuated inversion recovery. Consensus recommendations and response definitions have been established and, similar to other RAPNO recommendations, prospective validation in clinical trials is warranted.
引用
- Erker C, Tamrazi B, Poussaint TY, et al. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2020. PMID: 32502458. doi:10.1016/S1470-2045(20)30173-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。